Brought to you by 
Hypnion gets $47.5mm with Series B private placement
14 Apr 2003
Executive Summary
Hypnion (neuroscience drug discovery) has raised $47.5mm with the private placement of Series B shares. Lead investors Forward Ventures and MPM Capital were joined by new investors Advanced Technology Ventures, SR One, Jafco, and Coastview Capital. Returning investors Oxford Bioscience Partners, Flagship Ventures, and GIMV also participated.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hypnion gets $47.5mm with Series B private placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice